Crewe Advisors’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$16.9K Buy
71
+54
+318% +$11.2K ﹤0.01% 644
2026
Q1
$3.59K Buy
+17
New +$3.66K ﹤0.01% 833
2025
Q2
Sell
-21
Closed -$2.89K 760
2025
Q1
$2.89K Buy
+21
New +$2.68K ﹤0.01% 528
2024
Q4
Sell
-55
Closed -$6.08K 668
2024
Q3
$6.08K Hold
55
﹤0.01% 548
2024
Q2
$5.41K Sell
55
-83
-60% -$8.46K ﹤0.01% 785
2024
Q1
$15.4K Buy
+138
New +$14.9K ﹤0.01% 539
2023
Q3
Sell
-3
Closed -$284 635
2023
Q2
$284 Buy
+3
New +$253 ﹤0.01% 678
2023
Q1
Sell
-36
Closed -$2.77K 844
2022
Q4
$2.77K Sell
36
-141
-80% -$10.7K ﹤0.01% 783
2022
Q3
$12K Buy
177
+59
+50% +$3.74K ﹤0.01% 601
2022
Q2
$6K Buy
+118
New +$6.71K ﹤0.01% 711

Other funds holding CAH

Crewe Advisors's CAH Position: Q2 2026 in Review

Crewe Advisors increased its Cardinal Health (CAH) stake by 318% in Q2 2026, buying an estimated $11.2K and bringing the position to 71 shares worth $16.9K. The position accounts for ﹤0.01% of the portfolio, ranked #644.

Crewe Advisors first reported a position in CAH in Q2 2022 and has held it in 10 quarters since. 1,500 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Crewe Advisors held 71 shares of Cardinal Health worth $16.9K as of Q2 2026.
  • Crewe Advisors bought 54 Cardinal Health shares in Q2 2026, an estimated $11.2K.
  • Cardinal Health made up ﹤0.01% of Crewe Advisors's portfolio in Q2 2026, its #644 holding.
  • Crewe Advisors first reported a position in Cardinal Health in Q2 2022 and has held it in 10 quarters since.
  • 1,500 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Crewe Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.